FDA OKs new coagulation formulation
Monday, May 12, 2008 - 11:49
in Health & Medicine
WASHINGTON, May 12 (UPI) -- The U.S. Food and Drug Administration announced approval of a new formulation of the genetically engineered version of Factor VIIa, a coagulation therapy.